Flow cytometry Market - Global Industry Analysis

Flow cytometry Market By Technology (Cell-based Flow Cytometry, Bead-based Flow Cytometry) By Product and Service (Reagents and Consumables, Instruments, Services, Software, Accessories) By Application (Research Applications, Clinical Applications, Industrial Applications) By End User (Academic & Research Institutes, Hospitals & Clinical Testing Laboratories, Pharmaceutical & Biotechnology Companies), by : Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028

Published Date: 18-Jun-2021 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-2735 Status : Published

The global flow cytometry market was valued at USD 6,159.0 Million in 2020 is expected to reach USD 12,384.5 Million in 2028 growing at a CAGR of 9.2% between 2021 and 2028

Description

Market Overview

The global flow cytometry market was valued at USD 6,159.0 Million in 2020 is expected to reach USD 12,384.5 Million in 2028 growing at a CAGR of 9.2% between 2021 and 2028

Flow cytometry is a technique for swiftly analyzing single cells or particles that are suspended in a buffered salt-based solution and flow past one or more lasers. Visible light scatter and one or more fluorescence characteristics are assessed for each particle.

Flow cytometry is a versatile technology with applications in immunology, virology, molecular biology, cancer biology, and infectious disease surveillance, among other fields. It's great for studying the immune system and how it responds to infectious diseases and cancer, for example. It enables the characterization of mixed populations of cells from blood and bone marrow, as well as solid tissues that can be dissociated into single cells, such as lymph nodes, spleen, mucosal tissues, solid tumors, and so on.

COVID-19 Impact Analysis:

For all business sectors around the world, the coronavirus pandemic has produced a health problem as well as a difficult situation. During this pandemic, many national governments have provided guidelines to perform a clinical trial, perceiving the objective of the value of patient safety and protecting the credibility of the trial. In order to maintain the impact of the pandemic, the guidelines identified the need to adjust the trial and suggested that the regulatory agencies be flexible in the composition of the protocol adjustments. The bio-pharma industries have shifted their attention on developing the vaccines and therapies in rebound to the Covid-19 and the pressure of the crisis that is putting on the medical centers worldwide. There was concern about the effect on the global economy of a U.S.-China trade war, the U.S. presidential election, and Brexit in 2019. The IMF had therefore projected modest global growth of almost 3.4%, but Covid-19 suddenly modified the outlook. In terms of financial turnover, the clinical trial industry has increased further, for example, in India, the clinical trials industry has grown by 100 times at the rate of nearly 1414 percent annually between 2003 and 2010. Most industries accept that the guidance is a framework for drug developers to move dynamically forward and respond to trial changes and to tackle the unusual challenges with independence.

Growth Factors

Over the past few decades, there is rising prevalence of oncology disease across the developed and developing countries. 3D cell culturing makes it easy to develop new drug. 3D cell cultures are generally used in preclinical trials to test the pharmacodynamic and pharmacokinetic effects of new or novel drug/ medicine. 3D cell culturing is fulfilling the rising demand of drug discovery for chronic diseases. According to the Centers for Disease Control and Prevention (CDC) in the 2019, almost 6 in 10 people in the US suffer from at least one oncology disease and 4 in 10 people have two or more oncology diseases.

Cancer is one of the leading causes of death among population worldwide. The American Cancer Society (ACS) estimated that, approximately 1,735,350 new cancer cases were diagnosed in 2018. 3D scaffolds and 3D cell spheroids in vitro are useful in testing the pharmacokinetic effects of ontological drugs in preclinical trails. For instance, CellASIC ONIX Gradient Plate is the microfluidic system offered by Sigma Aldrich. It will drive the 3D cell culture market in the forecasted period. The expression of cell surface and intracellular compounds can be studied using flow cytometry. It helps measure the purity of isolated subpopulations by characterizing and defining different types of cells in a heterogeneous cell population.

The introduction of new products and the widespread use of 3D protocols in biological research are two other important drivers driving market expansion. For example, eNUVIO Inc., a biotechnology company based in Canada, launched EB-Plate, a 100% reusable microplate for 3D cell culture, in December 2020. This is projected to reduce single-use plastic waste, boost the utility of 3-dimensional microplates, and encourage laboratories to go zero-waste.

Such developments in 3D cell culture market are expected to bolster the demand for flow cytometry market during the years to come.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Application Segment Analysis Preview

Flow cytometry in medicine and research is utilized in detection and measurement of protein expression and post-translational modifications. Flow cytometry is used for applications like immunology, cell sorting, apoptosis, cell cycle analysis, cell viability, and cell counting. Presence of specific antigens is utilized for diagnosing acute leukemias, chronic lymphoproliferative diseases, and malignant lymphomas. Flow cytometry has gained traction as a vital analytical tool for diagnosis, prognosis, and monitoring. Adoption of new laser technologies in research among institutions has accelerated the demand for advance flow cytometry systems, which should fuel the flow cytometry market in research applications.

Regional Analysis Preview

North America region dominated the global flow cytometry market in 2020 and is expected to dominate the market in 2028. United States and Canada have experienced significant growth in development of new point of care diagnostics and testing technologies and increase in the number of medical and diagnostic laboratories. The point of care diagnostics and testing market in United States should reach to a market value of approximately USD 27.5 Billion by 2022, owing to advancement in diagnostics and testing and increasing awareness among individuals regarding health awareness. Further, presence of major vendors operating in the flow cytometry market in North America should also drive the adoption of new technologies by organizations and institutions as companies are introducing new products into the market, which may generate new opportunities for the market growth

Europe has foreseen rise in investment in research from government and private organizations in stem cell therapies and research, which has been driving the Europe stem cell market. According to Eurostat, in 2018, over 30 000 patients in the European Union (EU) received healthy blood-forming cells (stem cells) to replace their own that had been destroyed. Stem cell transplants in Germany, France, Italy, UK, and Spain were 7,700, 5,500, 5,100, 3,800, and 3,100 respectively in 2018. Further, cell research in Europe has increased as companies focus on developing advance cell therapies for treating disease, which is anticipated to stimulate the Europe flow cytometry market growth.

Key Market Players & Competitive Landscape

Some of key players in flow cytometry market are Becton, Dickinson and Company, Merck & Co., Inc., Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Sysmex Corporation, Alere, Inc., Miltenyi Biotec, Agilent Technologies, Inc., Bio-Techne, and Bio-Rad Laboratories, Inc., among others.

The global flow cytometry market is segmented as follows:

Technology Segment Analysis

  • Cell-based Flow Cytometry
  • Bead-based Flow Cytometry

 Product and Service Segment Analysis

  • Reagents and Consumables
  • Instruments
    • Cell Analyzers
      • High-Range
      • Mid-Range
      • Low-Range
    • Cell Sorters
      • High-Range
      • Mid-Range
      • Low-Range
  • Services
  • Software
  • Accessories

Application Segment Analysis

  • Research Applications
    • Pharmaceuticals and Biotechnology
    • Immunology
    • Cell Sorting
    • Apoptosis
    • Cell Cycle Analysis
    • Cell Viability
    • Cell Counting
    • Other
  • Clinical Applications
    • Cancer Diagnostics
    • Hematology
    • Immunodeficiency Diseases
    • Organ Transplantation
    • Other
  • Industrial Applications

End User Segment Analysis

  • Academic & Research Institutes
  • Hospitals & Clinical Testing Laboratories
  • Pharmaceutical & Biotechnology Companies

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Technology
        • 2.1.1.2. Market Attractiveness Analysis, By Product and Service
        • 2.1.1.3. Market Attractiveness Analysis, By Cell Analyzers
        • 2.1.1.4. Market Attractiveness Analysis, By Cell Sorters
        • 2.1.1.5. Market Attractiveness Analysis, By Application
        • 2.1.1.6. Market Attractiveness Analysis, By Research Application
        • 2.1.1.7. Market Attractiveness Analysis, By Clinical Application
        • 2.1.1.8. Market Attractiveness Analysis, By End User
        • 2.1.1.9. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Flow Cytometry Market, 2016 – 2028 (USD Million)
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
      • 3.2.1. Short Term Dynamics
      • 3.2.2. Long Term Dynamics
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
  • Chapter No. 4 Flow Cytometry Market – Technology Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Technology, 2020 & 2028
    • 4.2. Cell-based Flow Cytometry
    • 4.3. Bead-based Flow Cytometry
  • Chapter No. 5 Flow Cytometry Market – Product and Service Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Product and Service, 2020 & 2028
    • 5.2. Reagents and Consumables
    • 5.3. Instruments
    • 5.4. Services
    • 5.5. Software
    • 5.6. Accessories
  • Chapter No. 6 Flow Cytometry Market – Instruments Segment Analysis
    • 6.1. Flow Cytometry Market – Instruments Segment
      • 6.1.1. Market Revenue Share, By Instruments, 2020 & 2028
    • 6.2. Cell Analyzers
    • 6.3. Cell Sorters
  • Chapter No. 7 Flow Cytometry Market – Cell Analyzers Segment Analysis
    • 7.1. Flow Cytometry Market – Cell Analyzers Segment
      • 7.1.1. Market Revenue Share, By Cell Analyzers, 2020 & 2028
    • 7.2. High-Range
    • 7.3. Mid-Range
    • 7.4. Low-Range
  • Chapter No. 8 Flow Cytometry Market – Cell Sorters Segment Analysis
    • 8.1. Flow Cytometry Market – Cell Sorters Segment
      • 8.1.1. Market Revenue Share, By Cell Sorters, 2020 & 2028
    • 8.2. High-Range
    • 8.3. Mid-Range
    • 8.4. Low-Range
  • Chapter No. 9 Flow Cytometry Market – Application Segment Analysis
    • 9.1. Overview
      • 9.1.1. Market Revenue Share, By Application, 2020 & 2028
    • 9.2. Research Applications
    • 9.3. Clinical Applications
    • 9.4. Industrial Applications
  • Chapter No. 10: Flow Cytometry Market – Research Applications Segment Analysis
    • 10.1. Flow Cytometry Market – Research Applications Segment
      • 10.1.1. Market Revenue Share, By Research Applications, 2020 & 2028
    • 10.2. Pharmaceuticals and Biotechnulogy
    • 10.3. Immunulogy
    • 10.4. Cell Sorting
    • 10.5. Apoptosis
    • 10.6. Cell Cycle Analysis
    • 10.7. Cell Viability
    • 10.8. Cell Counting
    • 10.9. Other
  • Chapter No. 11: Flow Cytometry Market – Clinical Applications Segment Analysis
    • 11.1. Flow Cytometry Market – Clinical Applications Segment
      • 11.1.1. Market Revenue Share, By Clinical Applications, 2020 & 2028
    • 11.2. Cancer Diagnostics
    • 11.3. Hematulogy
    • 11.4. Immunodeficiency Diseases
    • 11.5. Organ Transplantation
    • 11.6. Other
  • Chapter No. 12: Flow Cytometry Market – End User Segment Analysis
    • 12.1. Overview
      • 12.1.1. Market Revenue Share, By End User, 2020 & 2028
    • 12.2. Academic & Research Institutes
    • 12.3. Hospitals & Clinical Testing Laboratories
    • 12.4. Pharmaceutical & Biotechnulogy Companies
  • Chapter No. 13: Flow Cytometry Market – Regional Analysis
    • 13.1. Overview
      • 13.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 13.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Million)
    • 13.2. North America
      • 13.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 13.2.2. North America Market Revenue, By Technology, 2016 – 2028
      • 13.2.3. North America Market Revenue, By Product and Service, 2016 – 2028
      • 13.2.4. North America Market Revenue, By Instruments, 2016 – 2028
      • 13.2.5. North America Market Revenue, By Cell Analyzers, 2016 – 2028
      • 13.2.6. North America Market Revenue, By Cell Sorters, 2016 – 2028
      • 13.2.7. North America Market Revenue, By Application, 2016 – 2028
      • 13.2.8. North America Market Revenue, By Research Applications, 2016 – 2028
      • 13.2.9. North America Market Revenue, By Clinical Applications, 2016 – 2028
      • 13.2.10. North America Market Revenue, By End User, 2016 – 2028
      • 13.2.11. U.S.
        • 13.2.11.1. U.S. Flow Cytometry Market Revenue, 2016 - 2028
      • 13.2.12. Canada
        • 13.2.12.1. Canada Flow Cytometry Market Revenue, 2016 - 2028
      • 13.2.13. Mexico
        • 13.2.13.1. Mexico Flow Cytometry Market Revenue, 2016 - 2028
    • 13.3. Europe
      • 13.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 13.3.2. Europe Market Revenue, By Technology, 2016 – 2028
      • 13.3.3. Europe Market Revenue, By Product and Service, 2016 – 2028
      • 13.3.4. Europe Market Revenue, By Instruments, 2016 – 2028
      • 13.3.5. Europe Market Revenue, By Cell Analyzers, 2016 – 2028
      • 13.3.6. Europe Market Revenue, By Cell Sorters, 2016 – 2028
      • 13.3.7. Europe Market Revenue, By Application, 2016 – 2028
      • 13.3.8. Europe Market Revenue, By Research Applications, 2016 – 2028
      • 13.3.9. Europe Market Revenue, By Clinical Applications, 2016 – 2028
      • 13.3.10. Europe Market Revenue, By End User, 2016 – 2028
      • 13.3.11. Germany
        • 13.3.11.1. Germany Flow Cytometry Market Revenue, 2016 - 2028
      • 13.3.12. France
        • 13.3.12.1. France Flow Cytometry Market Revenue, 2016 - 2028
      • 13.3.13. U.K.
        • 13.3.13.1. U.K. Flow Cytometry Market Revenue, 2016 - 2028
      • 13.3.14. Italy
        • 13.3.14.1. Italy Flow Cytometry Market Revenue, 2016 - 2028
      • 13.3.15. Spain
        • 13.3.15.1. Spain Flow Cytometry Market Revenue, 2016 - 2028
      • 13.3.16. Rest of Europe
        • 13.3.16.1. Rest of Europe Flow Cytometry Market Revenue, 2016 - 2028
    • 13.4. Asia Pacific
      • 13.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 13.4.2. Asia Pacific Market Revenue, By Technology, 2016 – 2028
      • 13.4.3. Asia Pacific Market Revenue, By Product and Service, 2016 – 2028
      • 13.4.4. Asia Pacific Market Revenue, By Instruments, 2016 – 2028
      • 13.4.5. Asia Pacific Market Revenue, By Cell Analyzers, 2016 – 2028
      • 13.4.6. Asia Pacific Market Revenue, By Cell Sorters, 2016 – 2028
      • 13.4.7. Asia Pacific Market Revenue, By Application, 2016 – 2028
      • 13.4.8. Asia Pacific Market Revenue, By Research Applications, 2016 – 2028
      • 13.4.9. Asia Pacific Market Revenue, By Clinical Applications, 2016 – 2028
      • 13.4.10. Asia Pacific Market Revenue, By End User, 2016 – 2028
      • 13.4.11. China
        • 13.4.11.1. China Flow Cytometry Market Revenue, 2016 - 2028
      • 13.4.12. Japan
        • 13.4.12.1. Japan Flow Cytometry Market Revenue, 2016 - 2028
      • 13.4.13. India
        • 13.4.13.1. India Flow Cytometry Market Revenue, 2016 - 2028
      • 13.4.14. South Korea
        • 13.4.14.1. South Korea Flow Cytometry Market Revenue, 2016 - 2028
      • 13.4.15. South-East Asia
        • 13.4.15.1. South-East Asia Flow Cytometry Market Revenue, 2016 - 2028
      • 13.4.16. Rest of Asia Pacific
        • 13.4.16.1. Rest of Asia Pacific Flow Cytometry Market Revenue, 2016 - 2028
    • 13.5. Latin America
      • 13.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 13.5.2. Latin America Market Revenue, By Technology, 2016 – 2028
      • 13.5.3. Latin America Market Revenue, By Product and Service, 2016 – 2028
      • 13.5.4. Latin America Market Revenue, By Instruments, 2016 – 2028
      • 13.5.5. Latin America Market Revenue, By Cell Analyzers, 2016 – 2028
      • 13.5.6. Latin America Market Revenue, By Cell Sorters, 2016 – 2028
      • 13.5.7. Latin America Market Revenue, By Application, 2016 – 2028
      • 13.5.8. Latin America Market Revenue, By Research Applications, 2016 – 2028
      • 13.5.9. Latin America Market Revenue, By Clinical Applications, 2016 – 2028
      • 13.5.10. Latin America Market Revenue, By End User, 2016 – 2028
      • 13.5.11. Brazil
        • 13.5.11.1. Brazil Flow Cytometry Market Revenue, 2016 - 2028
      • 13.5.12. Argentina
        • 13.5.12.1. Argentina Flow Cytometry Market Revenue, 2016 - 2028
      • 13.5.13. Rest of Latin America
        • 13.5.13.1. Rest of Latin America Flow Cytometry Market Revenue, 2016 - 2028
    • 13.6. The Middle-East and Africa
      • 13.6.1. The Middle East & Africa Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 13.6.2. The Middle East & Africa Market Revenue, By Technology, 2016 – 2028
      • 13.6.3. The Middle East & Africa Market Revenue, By Product and Service, 2016 – 2028
      • 13.6.4. The Middle East & Africa Market Revenue, By Instruments, 2016 – 2028
      • 13.6.5. The Middle East & Africa Market Revenue, By Cell Analyzers, 2016 – 2028
      • 13.6.6. The Middle East & Africa Market Revenue, By Cell Sorters, 2016 – 2028
      • 13.6.7. The Middle East & Africa Market Revenue, By Application, 2016 – 2028
      • 13.6.8. The Middle East & Africa Market Revenue, By Research Applications, 2016 – 2028
      • 13.6.9. The Middle East & Africa Market Revenue, By Clinical Applications, 2016 – 2028
      • 13.6.10. The Middle East & Africa Market Revenue, By End User, 2016 – 2028
      • 13.6.11. GCC Countries
        • 13.6.11.1. GCC Countries Flow Cytometry Market Revenue, 2016 - 2028
      • 13.6.12. South Africa
        • 13.6.12.1. South Africa Flow Cytometry Market Revenue, 2016 - 2028
      • 13.6.13. Rest of Middle-East Africa
        • 13.6.13.1. Rest of MEA Flow Cytometry Market Revenue, 2016 - 2028
  • Chapter No. 14: Flow Cytometry Market – Industry Analysis
    • 14.1. Introduction
    • 14.2. Market Drivers
      • 14.2.1. Rising prevalence of onculogy diseases
      • 14.2.2. High R&D investments in biotechnulogy, clinical, and life science research
    • 14.3. Market Restraints
      • 14.3.1. Restraining Factor Analysis
    • 14.4. Market Opportunities
      • 14.4.1. Growing Market Presence in Emerging Countries
    • 14.5. Porter’s Five Forces Analysis
      • 14.5.1. Bargaining Power of Buyers
      • 14.5.2. Threat of Substitutes
      • 14.5.3. Bargaining Power of Suppliers
      • 14.5.4. Industry Rivalry
      • 14.5.5. Threat of New Entrants
    • 14.6. PEST Analysis
      • 14.6.1. Pulitical
      • 14.6.2. Economical
      • 14.6.3. Social
      • 14.6.4. Technulogical
    • 14.7. Value Chain Analysis
      • 14.7.1.Twin Med, LLC
      • 14.7.2. Technology Landscape
      • 14.7.3. Technology Landscape
      • 14.7.4.. Market Trends
  • Chapter No. 15: Competitive Landscape
    • 15.1. Company Market Share Analysis – 2019
      • 15.1.1. Global Flow Cytometry Market: Company Market Share, 2019
    • 15.2. Strategic Developments
      • 15.2.1. Acquisitions & Mergers
      • 15.2.2. New Product Launch
  • Chapter No. 16: Company Profiles
    • 16.1. Becton, Dickinson and Company
      • 16.1.1. Company Overview
      • 16.1.2. Key Executives
      • 16.1.3. Product Portfolio
      • 16.1.4. Financial Overview
      • 16.1.5. Operating Business Segments
      • 16.1.6. Business Performance
      • 16.1.7. Recent Developments
    • 16.2. Beckman Coulter (A Subsidiary of Danaher)
      • 16.2.1. Company Overview
      • 16.2.2. Key Executives
      • 16.2.3. Product Portfolio
      • 16.2.4. Financial Overview
      • 16.2.5. Recent Developments
    • 16.3. Thermo Fisher Scientific
      • 16.3.1. Company Overview
      • 16.3.2. Key Executives
      • 16.3.3. Product Portfolio
      • 16.3.4. Financial Overview
      • 16.3.5. Operating Business Segments
      • 16.3.6. Business Performance
    • 16.4. Luminex Corporation
      • 16.4.1. Company Overview
      • 16.4.2. Key Executives
      • 16.4.3. Product Portfolio
      • 16.4.4. Financial Overview
      • 16.4.5. Business Performance
      • 16.4.6. Recent Developments
    • 16.5. Agilent Technulogies
      • 16.5.1. Company Overview
      • 16.5.2. Key Executives
      • 16.5.3. Product Portfolio
      • 16.5.4. Financial Overview
      • 16.5.5. Operating Business Segments
      • 16.5.6. Business Performance
      • 16.5.7. Recent Developments
    • 16.6. Sony Biotechnulogy (A Subsidiary of Sony Corporation of America)
      • 16.6.1. Company Overview
      • 16.6.2. Key Executives
      • 16.6.3. Product Portfolio
      • 16.6.4. Financial Overview
    • 16.7. Bio-Rad Laboratories
      • 16.7.1. Company Overview
      • 16.7.2. Key Executives
      • 16.7.3. Product Portfolio
      • 16.7.4. Financial Overview
      • 16.7.5. Operating Business Segments
      • 16.7.6. Business Performance
    • 16.8. Miltenyi Biotec
      • 16.8.1. Company Overview
      • 16.8.2. Key Executives
      • 16.8.3. Product Portfolio
      • 16.8.4. Financial Overview
    • 16.9. Enzo Biochem
      • 16.9.1. Company Overview
      • 16.9.2. Key Executives
      • 16.9.3. Product Portfolio
      • 16.9.4. Financial Overview
      • 16.9.5. Operating Business Segments
      • 16.9.6. Business Performance
  • Chapter No. 17: Marketing Strategy Analysis
    • 17.1. Marketing Channel
    • 17.2. Direct Marketing
    • 17.3. Indirect Marketing
    • 17.4. Marketing Channel Development Trends
  • Chapter No. 18: Research Methodology
    • 18.1. Research Methodology
    • 18.2. Phase I - Secondary Research
    • 18.3. Phase II - Data Modeling
      • 18.3.1. Company Share Analysis Model
      • 18.3.2. Revenue Based Modeling
    • 18.4. Phase III - Primary Research
    • 18.5. Research Limitations
      • 18.5.1. Assumptions

Table Of Figures

List of Figures

FIG NO. 1. Market Attractiveness Analysis, By Technology
FIG NO. 2. Market Attractiveness Analysis, By Product and Service
FIG NO. 3. Market Attractiveness Analysis, By Cell Analyzers
FIG NO. 4. Market Attractiveness Analysis, By Cell Sorters
FIG NO. 5. Market Attractiveness Analysis, By Application
FIG NO. 6. Market Attractiveness Analysis, By Research Application
FIG NO. 7. Market Attractiveness Analysis, By Clinical Application
FIG NO. 8. Market Attractiveness Analysis, By End User
FIG NO. 9. Market Attractiveness Analysis, By Region
FIG NO. 10. Global Flow Cytometry Market Revenue, 2016 – 2028 (USD Million)
FIG NO. 11. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 12. Impact of COVID-19 Pandemic in Europe Countries
FIG NO. 13. Impact of COVID-19 Pandemic in Asia Pacific Countries
FIG NO. 14. Impact of COVID-19 Pandemic in Latin America Countries
FIG NO. 15. Impact of COVID-19 Pandemic in The Middle East & Africa Countries
FIG NO. 16. Market Revenue Share, By Technology, 2020 & 2028
FIG NO. 17. Global Flow Cytometry Market for Cell-based Flow Cytometry, Revenue (USD Million) 2016 – 2028
FIG NO. 18. Global Flow Cytometry Market for Bead-based Flow Cytometry, Revenue (USD Million) 2016 – 2028
FIG NO. 19. Market Revenue Share, By Product and Service, 2020 & 2028
FIG NO. 20. Global Flow Cytometry Market for Reagents and Consumables, Revenue (USD Million) 2016 – 2028
FIG NO. 21. Global Flow Cytometry Market for Instruments, Revenue (USD Million) 2016 – 2028
FIG NO. 22. Global Flow Cytometry Market for Services, Revenue (USD Million) 2016 – 2028
FIG NO. 23. Global Flow Cytometry Market for Software, Revenue (USD Million) 2016 – 2028
FIG NO. 24. Global Flow Cytometry Market for Accessories, Revenue (USD Million) 2016 – 2028
FIG NO. 25. Market Revenue Share, By Instruments, 2020 & 2028
FIG NO. 26. Global Flow Cytometry Market for Cell Analyzers, Revenue (USD Million) 2016 – 2028
FIG NO. 27. Global Flow Cytometry Market for Cell Sorters, Revenue (USD Million) 2016 – 2028
FIG NO. 28. Market Revenue Share, By Cell Analyzers, 2020 & 2028
FIG NO. 29. Global Flow Cytometry Market for High-Range, Revenue (USD Million) 2016 – 2028
FIG NO. 30. Global Flow Cytometry Market for Mid-Range, Revenue (USD Million) 2016 – 2028
FIG NO. 31. Global Flow Cytometry Market for Low-Range, Revenue (USD Million) 2016 – 2028
FIG NO. 32. Market Revenue Share, By Cell Sorters, 2020 & 2028
FIG NO. 33. Global Flow Cytometry Market for High-Range, Revenue (USD Million) 2016 – 2028
FIG NO. 34. Global Flow Cytometry Market for Mid-Range, Revenue (USD Million) 2016 – 2028
FIG NO. 35. Global Flow Cytometry Market for Low-Range, Revenue (USD Million) 2016 – 2028
FIG NO. 36. Market Revenue Share, By Application, 2020 & 2028
FIG NO. 37. Global Flow Cytometry Market for Research Applications, Revenue (USD Million) 2016 – 2028
FIG NO. 38. Global Flow Cytometry Market for Clinical Applications, Revenue (USD Million) 2016 – 2028
FIG NO. 39. Global Flow Cytometry Market for Industrial Applications, Revenue (USD Million) 2016 – 2028
FIG NO. 40. Market Revenue Share, By Research Applications, 2020 & 2028
FIG NO. 41. Global Flow Cytometry Market for Pharmaceuticals and Biotechnology, Revenue (USD Million) 2016 – 2028
FIG NO. 42. Global Flow Cytometry Market for Immunology, Revenue (USD Million) 2016 – 2028
FIG NO. 43. Global Flow Cytometry Market for Cell Sorting, Revenue (USD Million) 2016 – 2028
FIG NO. 44. Global Flow Cytometry Market for Apoptosis, Revenue (USD Million) 2016 – 2028
FIG NO. 45. Global Flow Cytometry Market for Cell Cycle Analysis, Revenue (USD Million) 2016 – 2028
FIG NO. 46. Global Flow Cytometry Market for Cell Viability, Revenue (USD Million) 2016 – 2028
FIG NO. 47. Global Flow Cytometry Market for Cell Counting, Revenue (USD Million) 2016 – 2028
FIG NO. 48. Global Flow Cytometry Market for Other, Revenue (USD Million) 2016 – 2028
FIG NO. 49. Market Revenue Share, By Clinical Applications, 2020 & 2028
FIG NO. 50. Global Flow Cytometry Market for Cancer Diagnostics, Revenue (USD Million) 2016 – 2028
FIG NO. 51. Global Flow Cytometry Market for Hematology, Revenue (USD Million) 2016 – 2028
FIG NO. 52. Global Flow Cytometry Market for Immunodeficiency Diseases, Revenue (USD Million) 2016 – 2028
FIG NO. 53. Global Flow Cytometry Market for Organ Transplantation, Revenue (USD Million) 2016 – 2028
FIG NO. 54. Global Flow Cytometry Market for Other, Revenue (USD Million) 2016 – 2028
FIG NO. 55. Market Revenue Share, By End User, 2020 & 2028
FIG NO. 56. Global Flow Cytometry Market for Academic & Research Institutes, Revenue (USD Million) 2016 – 2028
FIG NO. 57. Global Flow Cytometry Market for Hospitals & Clinical Testing Laboratories, Revenue (USD Million) 2016 – 2028
FIG NO. 58. Global Flow Cytometry Market for Pharmaceutical & Biotechnology Companies, Revenue (USD Million) 2016 – 2028
FIG NO. 59. Global Flow Cytometry Market Revenue Share, By Region, 2020 & 2028
FIG NO. 60. North America Flow Cytometry Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 61. U.S. Flow Cytometry Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 62. Canada Flow Cytometry Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 63. Mexico Flow Cytometry Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 64. Europe Flow Cytometry Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 65. Germany Flow Cytometry Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 66. France Flow Cytometry Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 67. U.K. Flow Cytometry Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 68. Italy Flow Cytometry Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 69. Spain Flow Cytometry Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 70. Rest of Europe Flow Cytometry Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 71. Asia Pacific Flow Cytometry Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 72. China Flow Cytometry Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 73. Japan Flow Cytometry Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 74. India Flow Cytometry Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 75. South Korea Flow Cytometry Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 76. South-East Asia Flow Cytometry Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 77. Rest of Asia Pacific Flow Cytometry Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 78. Latin America Flow Cytometry Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 79. Brazil Flow Cytometry Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 80. Argentina Flow Cytometry Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 81. Rest of Latin America Flow Cytometry Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 82. The Middle East & Africa Flow Cytometry Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 83. GCC Countries Flow Cytometry Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 84. South Africa Flow Cytometry Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 85. Rest of MEA Flow Cytometry Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 86. Porter’s Five Forces Analysis for Global Flow Cytometry Market
FIG NO. 87. PEST Analysis for Global Flow Cytometry Market
FIG NO. 88. Value Chain Analysis for Global Flow Cytometry Market
FIG NO. 89. Company Share Analysis, 2019
FIG NO. 90. Becton, Dickinson and Company Business Segment Revenue Share, 2020 (%)
FIG NO. 91. Becton, Dickinson and Company Geographical Segment Revenue Share, 2020 (%)
FIG NO. 92. Thermo Fisher Scientific Business Segment Revenue Share, 2020 (%)
FIG NO. 93. Thermo Fisher Scientific Geographical Segment Revenue Share, 2020 (%)
FIG NO. 94. Luminex Corporation Business Segment Revenue Share, 2020 (%)
FIG NO. 95. Luminex Corporation Geographical Segment Revenue Share, 2020 (%)
FIG NO. 96. Agilent Technologies Business Segment Revenue Share, 2020 (%)
FIG NO. 97. Agilent Technologies Geographical Segment Revenue Share, 2020 (%)
FIG NO. 98. Bio-Rad Laboratories Business Segment Revenue Share, 2020 (%)
FIG NO. 99. Bio-Rad Laboratories Geographical Segment Revenue Share, 2020 (%)
FIG NO. 100. Bio-Rad Laboratories Business Segment Revenue Share, 2020 (%)
FIG NO. 101. Bio-Rad Laboratories Geographical Segment Revenue Share, 2020 (%)
FIG NO. 102. Research Methodology – Detailed View
FIG NO. 103. Research Methodology
 


Table Of Tables

List of Tables

TABLE NO. 1. Global Flow Cytometry Market: Snapshot
TABLE NO. 2. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
TABLE NO. 3. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
TABLE NO. 4. Global Flow Cytometry Market Revenue, By Region, 2016 – 2028 (USD Million)
TABLE NO. 5. North America Flow Cytometry Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 6. North America Flow Cytometry Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 7. North America Flow Cytometry Market Revenue, By Product and Service, 2016 – 2028 (USD Million)
TABLE NO. 8. North America Flow Cytometry Market Revenue, By Instruments, 2016 – 2028 (USD Million)
TABLE NO. 9. North America Flow Cytometry Market Revenue, By Cell Analyzers, 2016 – 2028 (USD Million)
TABLE NO. 10. North America Flow Cytometry Market Revenue, By Cell Sorters, 2016 – 2028 (USD Million)
TABLE NO. 11. North America Flow Cytometry Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 12. North America Flow Cytometry Market Revenue, By Research Applications, 2016 – 2028 (USD Million)
TABLE NO. 13. North America Flow Cytometry Market Revenue, By Clinical Applications, 2016 – 2028 (USD Million)
TABLE NO. 14. North America Flow Cytometry Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 15. Europe Flow Cytometry Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 16. Europe Flow Cytometry Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 17. Europe Flow Cytometry Market Revenue, By Product and Service, 2016 – 2028 (USD Million)
TABLE NO. 18. Europe Flow Cytometry Market Revenue, By Instruments, 2016 – 2028 (USD Million)
TABLE NO. 19. Europe Flow Cytometry Market Revenue, By Cell Analyzers, 2016 – 2028 (USD Million)
TABLE NO. 20. Europe Flow Cytometry Market Revenue, By Cell Sorters, 2016 – 2028 (USD Million)
TABLE NO. 21. Europe Flow Cytometry Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 22. Europe Flow Cytometry Market Revenue, By Research Applications, 2016 – 2028 (USD Million)
TABLE NO. 23. Europe Flow Cytometry Market Revenue, By Clinical Applications, 2016 – 2028 (USD Million)
TABLE NO. 24. Europe Flow Cytometry Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 25. Asia Pacific Flow Cytometry Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 26. Asia Pacific Flow Cytometry Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 27. Asia Pacific Flow Cytometry Market Revenue, By Product and Service, 2016 – 2028 (USD Million)
TABLE NO. 28. Asia Pacific Flow Cytometry Market Revenue, By Instruments, 2016 – 2028 (USD Million)
TABLE NO. 29. Asia Pacific Flow Cytometry Market Revenue, By Cell Analyzers, 2016 – 2028 (USD Million)
TABLE NO. 30. Asia Pacific Flow Cytometry Market Revenue, By Cell Sorters, 2016 – 2028 (USD Million)
TABLE NO. 31. Asia Pacific Flow Cytometry Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 32. Asia Pacific Flow Cytometry Market Revenue, By Research Applications, 2016 – 2028 (USD Million)
TABLE NO. 33. Asia Pacific Flow Cytometry Market Revenue, By Clinical Applications, 2016 – 2028 (USD Million)
TABLE NO. 34. Asia Pacific Flow Cytometry Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 35. Latin America Flow Cytometry Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 36. Latin America Flow Cytometry Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 37. Latin America Flow Cytometry Market Revenue, By Product and Service, 2016 – 2028 (USD Million)
TABLE NO. 38. Latin America Flow Cytometry Market Revenue, By Instruments, 2016 – 2028 (USD Million)
TABLE NO. 39. Latin America Flow Cytometry Market Revenue, By Cell Analyzers, 2016 – 2028 (USD Million)
TABLE NO. 40. Latin America Flow Cytometry Market Revenue, By Cell Sorters, 2016 – 2028 (USD Million)
TABLE NO. 41. Latin America Flow Cytometry Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 42. Latin America Flow Cytometry Market Revenue, By Research Applications, 2016 – 2028 (USD Million)
TABLE NO. 43. Latin America Flow Cytometry Market Revenue, By Clinical Applications, 2016 – 2028 (USD Million)
TABLE NO. 44. Latin America Flow Cytometry Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 45. The Middle East & Africa Flow Cytometry Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 46. The Middle East & Africa Flow Cytometry Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 47. The Middle East & Africa Flow Cytometry Market Revenue, By Product and Service, 2016 – 2028 (USD Million)
TABLE NO. 48. The Middle East & Africa Flow Cytometry Market Revenue, By Instruments, 2016 – 2028 (USD Million)
TABLE NO. 49. The Middle East & Africa Flow Cytometry Market Revenue, By Cell Analyzers, 2016 – 2028 (USD Million)
TABLE NO. 50. The Middle East & Africa Flow Cytometry Market Revenue, By Cell Sorters, 2016 – 2028 (USD Million)
TABLE NO. 51. The Middle East & Africa Flow Cytometry Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 52. The Middle East & Africa Flow Cytometry Market Revenue, By Research Applications, 2016 – 2028 (USD Million)
TABLE NO. 53. The Middle East & Africa Flow Cytometry Market Revenue, By Clinical Applications, 2016 – 2028 (USD Million)
TABLE NO. 54. The Middle East & Africa Flow Cytometry Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 55. Drivers for the Flow Cytometry Market: Impact Analysis
TABLE NO. 56. Restraints for the Flow Cytometry Market: Impact Analysis

Methodology

Free Analysis

Flow cytometry is a laser-based biophysical technology which has application in various fields such as protein engineering, biomarker detection, cell sorting, cell counting, cell analysis, etc. Flow cytometry analyzes fluid by suspending fluid in the light or laser beam. Cell components in the fluid are fluorescently labeled and then they are passed through beam which later on emits light by the laser at the diversified wavelength. The fluorescence light helps determine various properties of single particles and cells from different wavelengths.

Flow cytometry is used to detect various diseases like cancer, HIV, and hematological malignancies. According to the American Cancer Society, approximately 1 million new cancer cases were registered in U.S. Due to this increase in the number of cancer patients, demand for flow cytometry is high. Similarly, there is an increase in HIV patients across the globe, which is expected to further drive industry growth. Flow Cytometry has precise and accurate results over the traditional analytical methods; therefore there is an increase in demand for flow cytometry. The growth of flow cytometry market can also be attributed to the technological advancements in the techniques and also use of the method in research and diagnostic applications. However, high cost associated with the instrument and lack of technical experts hinders the market growth. Lack of awareness about the process also acts as a restraint for the growth of the market.

Global Flow Cytometry Market

Based on technology, the market is segmented into cell-based and bead-based. Cell-based Flow Cytometry is expected to dominate the market in the forecast period because of its various applications in different fields. Based on product, the market is segmented into reagents and consumables, instruments, software. The instrument segment is expected to dominate the global flow cytometry market. Based on application, the market is segmented into pharmaceutical and drug discovery, diagnostics and others category. Due to the increasing research in cancer and other infectious diseases, the research segment is anticipated to grow in the forecast period. Based on end users, the market is segmented into hospitals & diagnostic labs, academic and research institutions and others category. Academic and research institutions are expected to dominate the market in the forecast period.

Due to increase in advanced cell-based research activities, North America market is expected to dominate the overall global market in the forecast period. The Asia Pacific is expected to show the highest growth in the market because there is a significant increase in flow cytometry-based research. Growth in Latin America and the Middle East and Africa is expected to boost in the forecast period due to the use of flow cytometry in drug development.

Some of the key players in the food ingredients sterilization market are Becton, Dickinson and Company, Merck & Co., Inc., Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Sysmex Corporation, Alere, Inc., Miltenyi Biotec, Agilent Technologies, Inc., Bio-Techne, Bio-Rad Laboratories, Inc., and Others.

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The global flow cytometry market was valued at USD 6,159.0 Million in 2020.

The global flow cytometry market is expected to reach USD 12,384 Million by 2028, growing at a CAGR of 9.2% between 2021 to 2028.

Flow cytometry aids in the diagnosis and categorization of leukemia, as well as the differentiation of lymphoid from myeloid leukemia. Thus, increase of prevalence of oncology demographic is expected to propel the growth in the demand for flow cytometry during the forthcoming years

North America region dominated the global flow cytometry market in 2020 and is expected to dominate the market in 2028. United States and Canada have experienced significant growth in development of new point of care diagnostics and testing technologies and increase in the number of medical and diagnostic laboratories.

Some of key players in flow cytometry market are Becton, Dickinson and Company, Merck & Co., Inc., Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Sysmex Corporation, Alere, Inc., Miltenyi Biotec, Agilent Technologies, Inc., Bio-Techne, and Bio-Rad Laboratories, Inc., among others.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed